Apco Pharma Limited, a active public limited company, was established on 18 May 1994 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74899DL1994PLC059098. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.33 Cr.
It upholds a compliant status. Employing 20 professional, Its leadership includes Komal Setia (Director), Rishab Setia (Director), Prakash Setia (Managing Director). Past directors included Rishab Setia, Ashok Kumar Setia. It holds ₹6.91 Cr open charges and ₹7.68 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 359/25 Ignou Road Saiduljab, New Delhi, Delhi, 110030.
U74899DL1994PLC059098
059098
18 May 1994
₹5.00 Cr
₹2.33 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Apco Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Komal Setia | Director | 30 Sep 2004 | Current |
| Rishab Setia | Director | 01 Apr 2020 | Current |
| Prakash Setia | Managing Director | 01 Apr 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 14 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Apco Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.07% increase. The company also saw a substantial improvement in profitability, with a 77.95% increase in profit. The company's net worth moved up by a moderate rise of 3.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Apco Pharma had a promoter holding of 51.40% and a public holding of 48.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹69,094,978.00
₹76,807,120.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Sep 2024 | Others | ₹5.03 Cr | Open |
| 18 Aug 2021 | Tata Capital Financial Services Limited | ₹1.33 M | Open |
| 13 Nov 2010 | Bank Of Baroda | ₹1.75 Cr | Open |
| 13 Oct 2022 | Yes Bank Limited | ₹3.58 Cr | Satisfied |
| 19 Dec 2009 | The Bank Of Rajasthan Limited | ₹1.25 Cr | Satisfied |
Explore comprehensive loan charge details -
Apco Pharma has a workforce of 20 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Apco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apco Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 13 Oct 2022 via Charge ID 100626353 with Yes Bank Limited was fully satisfied on 25 Nov 2024. was recorded as a recent event.
Progress on Apco Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Others amounted to Rs. 5.03 Cr with Charge ID 101005241 was registered on 26 Sep 2024. was recorded as a recent event.
Apco Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
A charge with Yes Bank Limited of Rs. 3.58 Cr registered on 13 Oct 2022 with Charge ID 100626353 was modified on 12 Dec 2023. was recorded as a recent event.
The activity A charge with Yes Bank Limited amounted to Rs. 3.58 Cr with Charge ID 100626353 was registered on 13 Oct 2022. was completed.
The CIN of Apco Pharma Limited is U74899DL1994PLC059098.
Apco Pharma Limited is headquartered at 359/25 Ignou Road Saiduljab, New Delhi, Delhi, 110030.
Apco Pharma Limited was incorporated on 18 May 1994.
The current directors of Apco Pharma Limited are
The primary industry of Apco Pharma Limited is Manufacturing.
Apco Pharma Limited is unlisted.
The authorized capital of Apco Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹2.33 Cr.
The compliance status of Apco Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX